|
SRC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.0991207943789E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.00009994624872E-09 |
| Normal-vs-Stage2 |
2.030400E-02 |
| Normal-vs-Stage3 |
2.763400E-03 |
| Normal-vs-Stage4 |
3.231700E-02 |
| Stage1-vs-Stage2 |
4.129400E-01 |
| Stage1-vs-Stage3 |
2.676000E-01 |
| Stage1-vs-Stage4 |
9.891600E-01 |
| Stage2-vs-Stage3 |
9.552200E-01 |
| Stage2-vs-Stage4 |
4.768200E-01 |
| Stage3-vs-Stage4 |
3.711600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.94100291395216E-12 |
| Normal-vs-AfricanAmerican |
1.57189999999696E-05 |
| Normal-vs-Asian |
2.637800E-01 |
| Caucasian-vs-AfricanAmerican |
1.623660E-02 |
| Caucasian-vs-Asian |
6.120600E-01 |
| AfricanAmerican-vs-Asian |
4.537600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.10353956475728E-12 |
| Normal-vs-Female |
1.51569999995438E-07 |
| Male-vs-Female |
4.747600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.663270E-03 |
| Normal-vs-Extreme_Weight |
5.36469999978806E-07 |
| Normal-vs-Obese |
1.07859999998183E-06 |
| Normal-vs-Extreme_Obese |
1.785820E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.737200E-01 |
| Normal_Weight-vs-Obese |
8.191600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.821000E-01 |
| Extreme_Weight-vs-Obese |
1.814150E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.834800E-01 |
| Obese-vs-Extreme_Obese |
8.210200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.66349999999716E-05 |
| Normal-vs-Age(41-60Yrs) |
4.12914147318588E-12 |
| Normal-vs-Age(61-80Yrs) |
2.71950000296783E-08 |
| Normal-vs-Age(81-100Yrs) |
1.256440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.686400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.981800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.161630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.721000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.136440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.033620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.01416661127496E-12 |
| Normal-VS-Type2 PRCC |
1.224990E-04 |
| Normal-VS-KIRP CIMP |
7.538000E-02 |
| Normal-VS-Unclassified PRCC |
2.246000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.087200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.282800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.258800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.060200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.652000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.179590E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.781800E-04 |
| Normal-vs-N1 |
2.058600E-03 |
| Normal-vs-N2 |
2.556100E-02 |
| N0-vs-N1 |
2.880000E-01 |
| N0-vs-N2 |
1.656160E-01 |
| N1-vs-N2 |
4.462100E-02 |
|
|
